eFFECTOR Therapeutics- Warrants (26/08/2026) Overview
eFFECTOR Therapeutics- Warrants (26/08/2026) Discounted Cash Flow
DCF Analysis for EFTRW.
Get informed when a big investor buys or sells
+ FollowFair Value
$-2.09
Current Fair Value
$-2.09
↓ 348383.3% Downside
Overvalued by 348383.3% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison